CoChat

Pharmacokinetic and pharmacodynamic effects of methylphenidate and MDMA administered alone or in combination

Open access
Hysek, Cédric M., Simmler, Linda D., Schillinger, Nathalie, Meyer, Nicole, Schmid, Yasmin, Donzelli, Massimiliano, Grouzmann, Eric, Liechti, Matthias E. · 2014 · The International Journal of Neuropsychopharmacology
Cited by 126

The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.

Abstract

Methylphenidate and 3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy') are widely misused psychoactive drugs. Methylphenidate increases brain dopamine and norepinephrine levels by blocking the presynaptic reuptake transporters. MDMA releases serotonin, dopamine and norepinephrine through the same transporters. Pharmacodynamic interactions of methylphenidate and MDMA are likely. This study compared the pharmacodynamic and pharmacokinetic effects of methylphenidate and MDMA administered alone or in combination in healthy subjects using a double-blind, placebo-controlled, crossover design. Methylphenidate did not enhance the psychotropic effects of MDMA, although it produced psychostimulant effects on its own. The haemodynamic and adverse effects of co-administration of methylphenidate and MDMA were significantly higher compared with MDMA or methylphenidate alone. Methylphenidate did not change the pharmacokinetics of MDMA and vice versa. Methylphenidate and MDMA shared some subjective amphetamine-type effects; however, 125 mg of MDMA increased positive mood more than 60 mg of methylphenidate, and methylphenidate enhanced activity and concentration more than MDMA. Methylphenidate and MDMA differentially altered facial emotion recognition. Methylphenidate enhanced the recognition of sad and fearful faces, whereas MDMA reduced the recognition of negative emotions. Additionally, the present study found acute pharmacodynamic tolerance to MDMA but not methylphenidate. In conclusion, the combined use of methylphenidate and MDMA does not produce more psychoactive effects compared with either drug alone, but potentially enhances cardiovascular and adverse effects. The findings may be of clinical importance for assessing the risks of combined psychostimulant misuse. Trial registration identification number: NCT01465685 (http://clinicaltrials.gov/ct2/show/NCT01465685).

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1017/s1461145713001132

Cites

8 of 8 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 8 references

Research works printed but not linked: 35

  1. 10.1177/0269881107083639 · DOI · Paper page
  2. 10.1007/s00213-012-2708-y · DOI · Paper page
  3. 2007, Psychopharmacol, 189, 489
  4. 10.1021/ac4004584 · DOI · Paper page
  5. 2003, Psychopharmacol (Berl), 166, 95, 10.1007/s00213-002-1303-z · DOI
  6. 2012, Front Genet, 3, 1
  7. 10.1124/jpet.104.067116 · DOI · Paper page
  8. 10.1016/j.drugalcdep.2005.09.003 · DOI
  9. 1994, Eur J Clin Pharmacol, 46, 441, 10.1007/BF00191908 · DOI
  10. 10.1159/000084163 · DOI
  11. 10.1016/0893-133X(95)00117-V · DOI
  12. 2013, Neuropsychopharmacol, 38, 1079
  13. 1963, Br Med Bull, 19, 132, 10.1093/oxfordjournals.bmb.a070031 · doi:10.1093/oxfordjournals.bmb.a070031
  14. 10.1002/syn.20804 · DOI
  15. 10.1176/appi.ajp.163.7.1149 · doi:10.1176/appi.ajp.163.7.1149 · Paper page
  16. 10.1038/sj.npp.1300979 · DOI · Paper page
  17. 10.1111/j.1360-0443.2005.00944.x · DOI · Paper page
  18. 1971, Clin Pharmacol Ther, 12, 245, 10.1002/cpt1971122part1245 · DOI · Paper page
  19. 10.1177/026988110001400313 · DOI · Paper page
  20. 10.1016/j.biopsych.2012.04.005 · DOI · Paper page
  21. 1978, Die Eigenschaftswörterliste
  22. 2003, Psychopharmacol (Berl), 166, 264, 10.1007/s00213-002-1340-7 · DOI
  23. 10.1097/JCP.0b013e3182979d32 · DOI · Paper page
  24. 10.1124/jpet.111.188425 · DOI
  25. 10.1111/j.1476-5381.2012.01936.x · DOI · Paper page
  26. 10.1038/clpt.2011.78 · DOI · Paper page
  27. 10.1007/s00213-012-2761-6 · DOI
  28. 1976, Die Beschwerden-Liste. Münchener Informationssystem
  29. 10.1186/1471-2210-6-6 · DOI · Paper page
  30. 10.1016/j.pbb.2006.06.023 · DOI
  31. 10.1124/jpet.107.129056 · DOI
  32. 10.1111/j.1465-3362.2011.00324.x · DOI
  33. 10.1007/s00213-009-1545-0 · DOI
  34. 10.1016/0024-3205(87)90060-9 · DOI
  35. 1995, J Clin Endocrinol Metab, 80, 3009

Cited by

See all 126

Metadata

Authors
Hysek, C. M., Simmler, L. D., Schillinger, N., Meyer, N., Schmid, Y., Donzelli, M., Grouzmann, E., & Liechti, M. E.
Venue
The International Journal of Neuropsychopharmacology
Published
2013-10-08
Volume
17
Issue
03
Pages
371-381
ISSN
  • 1461-1457 (ISSN-L)
  • 1469-5111
OpenAlex
W2007520100
Cited by
126
References
8
FWCI
11.99
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Pharmacokinetic and pharmacodynamic effects of methylphenidate and MDMA administered alone or in combination. https://app.cochat.ai/papers/10.1017/s1461145713001132
The paper
Hysek, C. M., Simmler, L. D., Schillinger, N., Meyer, N., Schmid, Y., Donzelli, M., Grouzmann, E., & Liechti, M. E. (2014). Pharmacokinetic and pharmacodynamic effects of methylphenidate and MDMA administered alone or in combination. The International Journal of Neuropsychopharmacology. https://doi.org/10.1017/s1461145713001132

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.